Psychological stress, cognitive decline and the development of dementia in amnestic mild cognitive impairment.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
27 02 2020
Historique:
received: 19 07 2019
accepted: 10 02 2020
entrez: 29 2 2020
pubmed: 29 2 2020
medline: 21 11 2020
Statut: epublish

Résumé

To determine the relationship between psychological stress with cognitive outcomes in a multi-centre longitudinal study of people with amnestic mild cognitive impairment (aMCI) we assessed three parameters of psychological stress (Recent Life Changes Questionnaire (RLCQ); the Perceived Stress Scale (PSS) and salivary cortisol) and their relationship with rates of cognitive decline over an 18 month follow up period and conversion to dementia over a 5.5 year period. In 133 aMCI and 68 cognitively intact participants the PSS score was higher in the aMCI compared with control group but neither the RLCQ scores nor salivary cortisol measures were different between groups. In the aMCI group the RLCQ and the PSS showed no significant association with cognitive function at baseline, cognitive decline or with conversion rates to dementia but high salivary cortisol levels were associated with RLCQ scores and poorer cognitive function at baseline and lower rates of cognitive decline. No relationship was found between salivary cortisol levels and conversion rate to dementia. We conclude that psychological stress as measured by the RLCQ or PSS was not associated with adverse cognitive outcomes in an aMCI population and hypothesise that this may reflect diminished cortisol production to psychological stress as the disease progresses.

Identifiants

pubmed: 32108148
doi: 10.1038/s41598-020-60607-0
pii: 10.1038/s41598-020-60607-0
pmc: PMC7046646
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

3618

Subventions

Organisme : Alzheimer's Society
ID : PG 143/150
Pays : International
Organisme : Alzheimer's Society
ID : PG 143/150
Pays : International
Organisme : Alzheimer's Society
ID : PG 143/150
Pays : International
Organisme : Alzheimer's Society
ID : PG 143/150
Pays : International
Organisme : Alzheimer's Society
ID : PG 143/150
Pays : International
Organisme : Alzheimer's Society
ID : PG 143/150
Pays : International
Organisme : Alzheimer's Society
ID : PG 143/150
Pays : International
Organisme : Alzheimer's Society
ID : PG 143/150
Pays : International
Organisme : Alzheimer's Society
ID : PG 143/150
Pays : International
Organisme : Alzheimer's Society
ID : PG 143/150
Pays : International
Organisme : Alzheimer's Society
ID : PG 143/150
Pays : International
Organisme : Alzheimer's Society
ID : PG 143/150
Pays : International

Références

Petersen, R. C. et al. Prevalence of mild cognitive impairment is higher in men. The Mayo Clinic Study of Aging. Neurol. 75, 889–897 (2010).
doi: 10.1212/WNL.0b013e3181f11d85
Tschanz, J. T. et al. Conversion to dementia from mild cognitive disorder: the Cache County Study. Neurol. 67, 229–234 (2006).
doi: 10.1212/01.wnl.0000224748.48011.84
Karp, A. et al. Relation of education and occupation-based socioeconomic status to incident Alzheimer’s disease. Am. J. Epidemiol. 159, 175–183 (2004).
pubmed: 14718220 doi: 10.1093/aje/kwh018
Gao, Y. et al. Depression as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies. Int. J. Geriatr. Psychiatry 28, 441–449 (2013).
pubmed: 22815126 doi: 10.1002/gps.3845
Katz, M. J. et al. Influence of Perceived Stress on Incident Amnestic Mild Cognitive Impairment: Results From the Einstein Aging Study. Alzheimer Dis. Assoc. Disord. 30, 93–98 (2016).
pubmed: 26655068 pmcid: 4877262 doi: 10.1097/WAD.0000000000000125
Koyanagi, A. et al. Perceived Stress and Mild Cognitive Impairment among 32,715 Community-Dwelling Older Adults across Six Low- and Middle-Income Countries. Gerontology 65, 155–163 (2019).
pubmed: 30199870 doi: 10.1159/000492177
Mirza, S. S. et al. Mild cognitive impairment and risk of depression and anxiety: A population-based study. Alzheimers Dement. 13, 130–139 (2017).
pubmed: 27520773 doi: 10.1016/j.jalz.2016.06.2361
Comijs, H., van den Kommer, T., Minnaar, R., Penninx, B. & Deeg, D. Accummulated and Differential Effects of Life Events on Cognitive Decline in Older Persons: Depending on Depression, Baseline Cognition, or APOE e4 status? J. Gerontology, Ser. B: Psychological Sci. Soc. Sci. 66, 111–120 (2011).
doi: 10.1093/geronb/gbr019
Tschanz, J. et al. Stressful life events and cognitive decline in late life: moderation by education and age. The Cache County Study. Int. J. Geriatr. Psychiatry 28, 821–830 (2013).
pubmed: 23037866 doi: 10.1002/gps.3888
Andel, R., Crowe, M., Kareholt, I., Wastesson, J. & Parker, M. G. Indicators of job strain at midlife and cognitive functioning in advanced old age. J. Gerontol. B Psychol. Sci. Soc. Sci 66, 287–291 (2011).
pubmed: 21292810 doi: 10.1093/geronb/gbq105 pmcid: 21292810
Leng, Y. et al. The association between social stress and global cognitive function in a population-based study: the European Prospective Investigation into Cancer (EPIC)-Norfolk study. Psychological Med. 43, 655–666 (2013).
doi: 10.1017/S0033291712001316
Comijs, H. C., van den Kommer, T. N., Minnaar, R. W., Penninx, B. W. & Deeg, D. J. Accumulated and differential effects of life events on cognitive decline in older persons: depending on depression, baseline cognition, or ApoE epsilon4 status? J. Gerontol. B Psychol. Sci. Soc. Sci 66(Suppl 1), i111–120 (2011).
pubmed: 21422053 doi: 10.1093/geronb/gbr019
Tschanz, J. T. et al. Stressful life events and cognitive decline in late life: moderation by education and age. The Cache County Study. Int. J. Geriatr. Psychiatry 28, 821–830 (2013).
pubmed: 23037866 doi: 10.1002/gps.3888
Johansson, L. et al. Midlife psychological stress and risk of dementia: A 35-year longitudinal population study. Brain: A J. Neurol. 133, 2217–2224 (2010).
doi: 10.1093/brain/awq116
Persson, G. & Skoog, I. A prospective population study of psychosocial risk factors for late onset dementia. Int. J. Geriatric Psychiatry 11, 15–22 (1996).
doi: 10.1002/(SICI)1099-1166(199601)11:1<15::AID-GPS262>3.0.CO;2-5
Wilson, R. S. et al. Chronic distress and incidence of mild cognitive impairment. Neurol. 68, 2085–2092 (2007).
doi: 10.1212/01.wnl.0000264930.97061.82
Johansson, L. et al. Common psychosocial stressors in middle-aged women related to longstanding distress and increased risk of Alzheimer’s disease: A 38-year longitudinal population study. BMJ Open 3(2013).
Sundstrom, A., Ronnlund, M., Adolfsson, R. & Nilsson, L. G. Stressful life events are not associated with the development of dementia. Int. Psychogeriatr. 26, 147–154 (2014).
pubmed: 24182362 pmcid: 3854552 doi: 10.1017/S1041610213001804
Ouanes, S. et al. Life events, salivary cortisol, and cognitive performance in nondemented subjects: a population-based study. Neurobiol. Aging 51, 1–8 (2017).
pubmed: 28012996 doi: 10.1016/j.neurobiolaging.2016.11.014
Johansson, L. et al. Common psychosocial stressors in middle-aged women related to longstanding distress and increased risk of Alzheimer’s disease: a 38-year longitudinal population study. BMJ Open. 3, e003142 (2013).
pubmed: 24080094 pmcid: 3787482 doi: 10.1136/bmjopen-2013-003142
Peavy, G. M. et al. Effects of chronic stress on memory decline in cognitively normal and mildly impaired older adults. Am. J. Psychiatry 166, 1384–1391 (2009).
pubmed: 19755573 pmcid: 2864084 doi: 10.1176/appi.ajp.2009.09040461
Johansson, L. et al. Midlife psychological stress and risk of dementia: a 35-year longitudinal population study. Brain 133, 2217–2224 (2010).
pubmed: 20488887 doi: 10.1093/brain/awq116 pmcid: 20488887
Geda, Y. E. et al. Depression, apolipoprotein E genotype, and the incidence of mild cognitive impairment: a prospective cohort study. Arch. Neurol. 63, 435–440 (2006).
pubmed: 16533972 doi: 10.1001/archneur.63.3.435 pmcid: 16533972
Huot, R. L., Plotsky, P. M., Lenox, R. H. & McNamara, R. K. Neonatal maternal separation reduces hippocampal mossy fiber density in adult Long Evans rats. Brain Res. 950, 52–63 (2002).
pubmed: 12231228 doi: 10.1016/S0006-8993(02)02985-2 pmcid: 12231228
Sousa, N., Lukoyanov, N. V., Madeira, M. D., Almeida, O. F. & Paula-Barbosa, M. M. Reorganization of the morphology of hippocampal neurites and synapses after stress-induced damage correlates with behavioral improvement. Neurosci. 97, 253–266 (2000).
doi: 10.1016/S0306-4522(00)00050-6
Lupien, S. et al. Basal cortisol levels and cognitive deficits in human aging. J. Neurosci. 14, 2893–2903 (1994).
pubmed: 8182446 pmcid: 6577490 doi: 10.1523/JNEUROSCI.14-05-02893.1994
Miller, M. A. & Rahe, R. H. Life changes scaling for the 1990s. J. Psychosom. Res. 43, 279–292 (1997).
pubmed: 9304554 doi: 10.1016/S0022-3999(97)00118-9 pmcid: 9304554
Cohen, S., Kamarck, T. & Mermelstein, R. A global measure of perceived stress. J. Health Soc. Behav. 24, 385–396 (1983).
pubmed: 6668417 doi: 10.2307/2136404 pmcid: 6668417
Grober, E., Ocepek-Welikson & Tersei, J. A. The Free and Cued Selective Reminding. Test: Evid. psychometrci adequacy. Psychol. Sci. Q. 51, 266–282 (2009).
Nasreddine, Z. S. et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J. Am. Geriatr. Soc. 53, 695–699 (2005).
pubmed: 15817019 doi: 10.1111/j.1532-5415.2005.53221.x
Mitchell, A. J. & Shiri-Feshki, M. Rate of progression of mild cognitive impairment to dementia–meta-analysis of 41 robust inception cohort studies. Acta Psychiatr. Scand. 119, 252–265 (2009).
pubmed: 19236314 doi: 10.1111/j.1600-0447.2008.01326.x
Rozzini, L. et al. Neuropsychiatric symptoms in amnestic and nonamnestic mild cognitive impairment. Dement. Geriatr. Cogn. Disord. 25, 32–36 (2008).
pubmed: 18025827 doi: 10.1159/000111133
Hermida, A. P., McDonald, W. M., Steenland, K. & Levey, A. The association between late-life depression, mild cognitive impairment and dementia: is inflammation the missing link? Expert. Rev. Neurother. 12, 1339–1350 (2012).
pubmed: 23234395 pmcid: 4404497 doi: 10.1586/ern.12.127
Ouanes, S. & Popp, J. High Cortisol and the Risk of Dementia and Alzheimer’s Disease: A Review of the Literature. Front. Aging Neurosci. 11, 43 (2019).
pubmed: 30881301 pmcid: 6405479 doi: 10.3389/fnagi.2019.00043
Geerlings, M. I. et al. Salivary cortisol, brain volumes, and cognition in community-dwelling elderly without dementia. Neurol. 85, 976–983 (2015).
doi: 10.1212/WNL.0000000000001931
Pruessner, M., Pruessner, J. C., Hellhammer, D. H., Bruce Pike, G. & Lupien, S. J. The associations among hippocampal volume, cortisol reactivity, and memory performance in healthy young men. Psychiatry Res. 155, 1–10 (2007).
pubmed: 17395434 doi: 10.1016/j.pscychresns.2006.12.007
Bruehl, H., Wolf, O. T. & Convit, A. A blunted cortisol awakening response and hippocampal atrophy in type 2 diabetes mellitus. Psychoneuroendocrinology 34, 815–821 (2009).
pubmed: 19167831 pmcid: 2774914 doi: 10.1016/j.psyneuen.2008.12.010
Buchanan, T. W., Kern, S., Allen, J. S., Tranel, D. & Kirschbaum, C. Circadian regulation of cortisol after hippocampal damage in humans. Biol. Psychiatry 56, 651–656 (2004).
pubmed: 15522248 doi: 10.1016/j.biopsych.2004.08.014
Buchanan, T. W., Tranel, D. & Kirschbaum, C. Hippocampal damage abolishes the cortisol response to psychosocial stress in humans. Horm. Behav. 56, 44–50 (2009).
pubmed: 19281812 pmcid: 2692817 doi: 10.1016/j.yhbeh.2009.02.011
Wolf, O. T., Fujiwara, E., Luwinski, G., Kirschbaum, C. & Markowitsch, H. J. No morning cortisol response in patients with severe global amnesia. Psychoneuroendocrinology 30, 101–105 (2005).
pubmed: 15358447 doi: 10.1016/j.psyneuen.2004.05.001
Lehallier, B. et al. Combined Plasma and Cerebrospinal Fluid Signature for the Prediction of Midterm Progression From Mild Cognitive Impairment to Alzheimer Disease. JAMA Neurol. 73, 203–212 (2016).
pubmed: 26659895 doi: 10.1001/jamaneurol.2015.3135
Whitehair, D. C. et al. Influence of apolipoprotein E varepsilon4 on rates of cognitive and functional decline in mild cognitive impairment. Alzheimers Dement. 6, 412–419 (2010).
pubmed: 20813342 pmcid: 2943876 doi: 10.1016/j.jalz.2009.12.003
Xu, W. L. et al. Accelerated progression from mild cognitive impairment to dementia among APOE epsilon4epsilon4 carriers. J. Alzheimers Dis. 33, 507–515 (2013).
pubmed: 23247007 doi: 10.3233/JAD-2012-121369
Petersen, R. C. & Negash, S. Mild cognitive impairment: an overview. CNS Spectr. 13, 45–53 (2008).
pubmed: 18204414 doi: 10.1017/S1092852900016151
Petersen, R. C. et al. Mild cognitive impairment: clinical characterization and outcome. Arch. Neurol. 56, 303–308 (1999).
pubmed: 10190820 doi: 10.1001/archneur.56.3.303
Clements, A. D. Salivary cortisol measurement in developmental research: where do we go from here? Developmental Psychobiology 53, 205–220 (2013).
doi: 10.1002/dev.21025
Hellhammer, D. H., Wust, S. & Kudielka, B. M. Salivary cortisol as a biomarker in stress research. Psychoneuroendocrinology 34, 163–171 (2009).
pubmed: 19095358 doi: 10.1016/j.psyneuen.2008.10.026
Kudielka, B. M., Hellhammer, D. H. & Wust, S. Why do we respond so differently? Reviewing determinants of human salivary cortisol responses to challenge. Psychoneuroendocrinology 34, 2–18 (2009).
pubmed: 19041187 doi: 10.1016/j.psyneuen.2008.10.004
Butters, N., Granholm, E., Salmon, D. P., Grant, I. & Wolfe, J. Episodic and semantic memory: a comparison of amnesic and demented patients. J. Clin. Exp. Neuropsychol. 9, 479–497 (1987).
pubmed: 2959682 doi: 10.1080/01688638708410764
Wechsler, D.A. Weschsler Adult Intelligence Scale. (The psychological corporation, San Antonio, TX., 1997).
Reitan, R. M. Validity of the Trail Making Test as an indicator of organic brain damage. Percept. Mot. Skills. 8, 271–276 (1958).
doi: 10.2466/pms.1958.8.3.271
Sherbourne, C. D. & Stewart, A. L. The MOS social support survey. Soc. Sci. Med. 32, 705–714 (1991).
pubmed: 2035047 doi: 10.1016/0277-9536(91)90150-B pmcid: 2035047
WHO. The ICD-10 Classification of Mental and Behavioural Disorders, (World Health Organisation., Geneva, 1992).
Dressendorfer, R. A., Kirschbaum, C., Rohde, W., Stahl, F. & Strasburger, C. J. Synthesis of a cortisol-biotin conjugate and evaluation as a tracer in an immunoassay for salivary cortisol measurement. J. Steroid Biochem. Mol. Biol. 43, 683–692 (1992).
pubmed: 1472460 doi: 10.1016/0960-0760(92)90294-S pmcid: 1472460
Stalder, T. et al. Assessment of the cortisol awakening response: Expert consensus guidelines. Psychoneuroendocrinology 63, 414–432 (2016).
pubmed: 26563991 doi: 10.1016/j.psyneuen.2015.10.010 pmcid: 26563991
Norman, G. R., Sloan, J. A. & Wyrwich, K. W. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med. Care 41, 582–592 (2003).
pubmed: 12719681 pmcid: 12719681
Howard, R. et al. Determining the minimum clinically important differences for outcomes in the DOMINO trial. Int. J. Geriatr. Psychiatry 26, 812–817 (2011).
pubmed: 20848576 doi: 10.1002/gps.2607
Miller, G. A. The magical number seven plus or minus two: some limits on our capacity for processing information. Psychol. Rev. 63, 81–97 (1956).
pubmed: 13310704 doi: 10.1037/h0043158

Auteurs

Rebecca Sussams (R)

Faculty of Medicine, Clinical Experimental Sciences, University of Southampton, Southampton, UK.
Memory Assessment and Research Centre; Moorgreen Hospital; Southern Health Foundation Trust, Southampton, UK.

Wolff Schlotz (W)

MaxPlanckInstitut for Empirical Aesthetics, Frankfurt am Main, Germany.

Zoe Clough (Z)

Faculty of Medicine, Clinical Experimental Sciences, University of Southampton, Southampton, UK.
Memory Assessment and Research Centre; Moorgreen Hospital; Southern Health Foundation Trust, Southampton, UK.

Jay Amin (J)

Faculty of Medicine, Clinical Experimental Sciences, University of Southampton, Southampton, UK.
Memory Assessment and Research Centre; Moorgreen Hospital; Southern Health Foundation Trust, Southampton, UK.

Sharon Simpson (S)

St Mary's Community Health Campus, Solent health care trust, Portsmouth, UK.

Amelia Abbott (A)

Faculty of Medicine, Clinical Experimental Sciences, University of Southampton, Southampton, UK.
Memory Assessment and Research Centre; Moorgreen Hospital; Southern Health Foundation Trust, Southampton, UK.

Rebecca Beardmore (R)

Faculty of Medicine, Clinical Experimental Sciences, University of Southampton, Southampton, UK.
Memory Assessment and Research Centre; Moorgreen Hospital; Southern Health Foundation Trust, Southampton, UK.

Richard Sharples (R)

Memory Assessment and Research Centre; Moorgreen Hospital; Southern Health Foundation Trust, Southampton, UK.

Rachel Raybould (R)

Institute of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.

Keeley Brookes (K)

Human Genetics, School of Life Sciences, University of Nottingham, Nottingham, UK.

Kevin Morgan (K)

Human Genetics, School of Life Sciences, University of Nottingham, Nottingham, UK.

David Culliford (D)

NIHR CLAHRC Wessex Data Science Hub, Faculty of Health Sciences, University of Southampton, Southampton, UK.

Clive Holmes (C)

Faculty of Medicine, Clinical Experimental Sciences, University of Southampton, Southampton, UK. ch4@soton.ac.uk.
Memory Assessment and Research Centre; Moorgreen Hospital; Southern Health Foundation Trust, Southampton, UK. ch4@soton.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH